Post-IPO Equity - Moderna
Investment Firm
Overview
Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.
Announced Date
Mar 27, 2024
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Moderna raised $750000000 on 2024-03-27 in Post-IPO Equity
Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.
Company Funding History
15
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jan 14, 2014 |  Corporate Round - Moderna | 1 | - | 25.0M |
| Nov 20, 2013 | Venture Round - Moderna | 1 | - | 110.0M |
| Oct 02, 2013 | Grant - Moderna | 1 | - | 24.6M |
| Dec 06, 2012 | Venture Round - Moderna | 1 | - | 40.0M |
Recent Activity
There is no recent news or activity for this profile.